Title:
BRUTON TYROSINE KINASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2019/056466
Kind Code:
A1
Abstract:
The present invention relates to a compound having the structure of formula I or a pharmaceutically acceptable salt, solvate, active metabolite, polymorph, ester, optical isomer or prodrug thereof, a pharmaceutical composition comprising the compound having the structure of formula I, and an application of the compound, serving as a selective Bruton tyrosine kinase inhibitor, in the preparation of a medicine for preventing or treating heteroimmune diseases, autoimmune diseases, or cancers.
Inventors:
CHEN RONGYAO (CN)
Application Number:
PCT/CN2017/107638
Publication Date:
March 28, 2019
Filing Date:
October 25, 2017
Export Citation:
Assignee:
NANJING GENTAI PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07D487/04; A61K31/4985; A61K31/501; A61P11/06; A61P29/00; A61P35/00; A61P35/02; A61P37/02; A61P37/06
Domestic Patent References:
| WO2016109223A1 | 2016-07-07 |
Foreign References:
| CN103917545A | 2014-07-09 | |||
| CN106831789A | 2017-06-13 |
Attorney, Agent or Firm:
NANJING SUGAO PATENT AND TRADEMARK FIRM (ORDINARY PARTNERSHIP) (CN)
Download PDF:
Previous Patent: VIRTUAL CIRCUIT OF FLAT PANEL DISPLAY DEVICE AND DRIVING CIRCUIT
Next Patent: BURKHOLDERIA AND APPLICATIONS THEREOF
Next Patent: BURKHOLDERIA AND APPLICATIONS THEREOF